BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11991993)

  • 1. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.
    Pasquetto V; Wieland SF; Uprichard SL; Tripodi M; Chisari FV
    J Virol; 2002 Jun; 76(11):5646-53. PubMed ID: 11991993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice.
    Wieland SF; Guidotti LG; Chisari FV
    J Virol; 2000 May; 74(9):4165-73. PubMed ID: 10756029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment.
    Shi H; Lu L; Zhang NP; Zhang SC; Shen XZ
    World J Gastroenterol; 2012 Jul; 18(27):3617-22. PubMed ID: 22826629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
    Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
    Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.
    Biermer M; Puro R; Schneider RJ
    J Virol; 2003 Apr; 77(7):4033-42. PubMed ID: 12634363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
    Xia Y; Stadler D; Lucifora J; Reisinger F; Webb D; Hösel M; Michler T; Wisskirchen K; Cheng X; Zhang K; Chou WM; Wettengel JM; Malo A; Bohne F; Hoffmann D; Eyer F; Thimme R; Falk CS; Thasler WE; Heikenwalder M; Protzer U
    Gastroenterology; 2016 Jan; 150(1):194-205. PubMed ID: 26416327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes.
    Wieland SF; Vega RG; Müller R; Evans CF; Hilbush B; Guidotti LG; Sutcliffe JG; Schultz PG; Chisari FV
    J Virol; 2003 Jan; 77(2):1227-36. PubMed ID: 12502840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes.
    Kan Q; Li D; Yu Z
    J Virol Methods; 2012 Mar; 180(1-2):84-90. PubMed ID: 22240074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes.
    Suri D; Schilling R; Lopes AR; Mullerova I; Colucci G; Williams R; Naoumov NV
    J Hepatol; 2001 Dec; 35(6):790-7. PubMed ID: 11738107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids.
    Wieland SF; Eustaquio A; Whitten-Bauer C; Boyd B; Chisari FV
    Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9913-7. PubMed ID: 15994231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.
    Ebert G; Poeck H; Lucifora J; Baschuk N; Esser K; Esposito I; Hartmann G; Protzer U
    Gastroenterology; 2011 Aug; 141(2):696-706, 706.e1-3. PubMed ID: 21684282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice.
    Cavanaugh VJ; Guidotti LG; Chisari FV
    J Virol; 1997 Apr; 71(4):3236-43. PubMed ID: 9060687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.
    Guidotti LG; Morris A; Mendez H; Koch R; Silverman RH; Williams BR; Chisari FV
    J Virol; 2002 Mar; 76(6):2617-21. PubMed ID: 11861827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells.
    Caselmann WH; Meyer M; Scholz S; Hofschneider PH; Koshy R
    J Infect Dis; 1992 Nov; 166(5):966-71. PubMed ID: 1328410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of hepatitis B virus replication in Tupaia hepatocytes by tumor necrosis factor alpha of Tupaia belangeri.
    Xu Y; Köck J; Lu Y; Yang D; Lu M; Zhao X
    Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):361-8. PubMed ID: 21684599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma, tumor necrosis factor-alpha, and interleukin 1-beta suppress the replication of hepatitis B virus through oxidative stress.
    Togashi H; Ohno S; Matsuo T; Watanabe H; Saito T; Shinzawa H; Takahashi T
    Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):407-17. PubMed ID: 11589367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha and interferon-gamma inhibit synergistically viral replication in hepatitis B virus-replicating cells.
    Kawanishi Y; Hayashi N; Katayama K; Ueda K; Takehara T; Miyoshi E; Mita E; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1995 Nov; 47(3):272-7. PubMed ID: 8551280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
    Kladney RD; Cui X; Bulla GA; Brunt EM; Fimmel CJ
    Hepatology; 2002 Jun; 35(6):1431-40. PubMed ID: 12029628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.